[Practice guidelines for management of hepatocellular carcinoma 2009].
about
KASL clinical practice guidelines: management of chronic hepatitis BControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaMultimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaClinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusNew paradigm for management of hepatocellular carcinoma by imaging.Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinomaFeasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinomaBarcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.Strategies to tackle the challenges of external beam radiotherapy for liver tumorsEastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinomaA comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma.Role of radiofrequency ablation in patients with hepatocellular carcinoma who undergo prior transarterial chemoembolization: long-term outcomes and predictive factors.Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with obstructive jaundice.Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohortClinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation.Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective studyClinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutionsDifferent survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spreadRisk factors of cryptogenic hepatocellular carcinoma in patients with low body mass index or without metabolic syndrome.Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH).Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control studyLong-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma.The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care.The optimal selection of radiotherapy treatment for hepatocellular carcinomaThe clinical and laboratory characteristics of patients with chronic hepatitis B using current or past antiviral therapy in Korea: a multi-center, nation-wide, cross-sectional epidemiologic study.Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine AminotransferaseScheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinomaSLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma.Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.
P2860
Q26752475-88C49B63-55F3-46CD-811A-FAE55F848BD7Q26772324-BF5EACF6-17CE-4B55-B82B-FA7F337FE183Q26797643-A75291FE-10E8-49CF-A7FA-4B949E72C3ADQ28392783-5BD81B76-446D-48DD-93B7-AB6272D3B04CQ28394414-B9B5DEF7-7272-4453-B44F-54E2CC44FF8EQ30364978-9C2F448B-FC9E-4C49-ACA0-5FA9B263BD4EQ30374727-4D5EB94E-E854-45AA-B659-E54251CE8B0AQ30375738-171A17B5-E473-46A8-8ED0-333EB61B9A80Q30448048-75FF7B9B-DC54-47BB-AD61-B914012D18F3Q30455431-19B65A24-235B-4DB4-A953-0960CB7E2140Q31111026-9C8A96EB-C914-43AC-8EE6-9EE4D3FBAC09Q33409555-E1D925C1-7FC3-4DDE-A335-2B4ACBF37FA8Q33627217-B49C5DDE-80CC-4DFE-BF2B-7D4A9E7E6AC4Q33704156-626BE83A-C5BE-4909-8973-A71E80043EA1Q33706721-6F1364ED-9ECF-4E1E-8101-A1076FF12A13Q33742856-90DAEE57-5E4D-4623-8ABD-62843106A054Q34024535-79CB8264-20B9-4147-8633-BC4E61F411C2Q34182112-714837A4-A615-404C-8B02-9669ABFC04C3Q34182156-3E6F1C89-DE7E-4D19-AB44-E68A153A40A2Q34219619-7524FFC8-FD72-4D83-A698-D51548884440Q34459368-9E36BD53-F529-41FF-8B3D-D091244A98D0Q34799936-75F5EEEA-73F7-4E73-9077-24CFCB4C8445Q34959556-CF0F90A0-42A0-4356-AA3E-C992964E4859Q35025403-2E120D36-4B0D-423B-9B7D-52C2AB5FD758Q35158760-252CA7D4-64B9-49C6-AF18-7983039A8F5AQ35178728-58358A74-DEE3-4964-AA8B-587B6349E511Q35495325-5E002981-303A-4BA6-A83B-D5298482D63BQ35553137-29AF2C6C-0DC6-46D0-939F-0AE161DA5116Q35809855-9FC05F1E-7D80-4E43-80F8-5420FD143366Q35815800-EA1E9B28-83AB-4EAB-ADD3-D974BA60F75FQ35832967-23DCB07B-BFE8-4806-B1A4-226B8F2F313CQ35833037-566DCBDF-B447-4E8C-94D9-7A7D20832FD9Q35833182-413945A1-AF00-4CE4-8EAD-0E15DDCA4A1CQ35931183-C0849A90-6F6B-488C-B4FE-AC63DFC355C6Q35931235-3163C85B-99F4-4C2B-9265-9C9267354B0FQ36052952-C27A3162-541D-4AEF-AB6A-79C177CF7312Q36079026-39A2573B-51A7-463D-8EDD-C8A1BA2BA5E9Q36140832-41F5706C-60EC-4EC3-8375-19C822DD5D6BQ36152454-54FF16C9-50C4-4DB9-B20B-F485B1178F89Q36153966-B5EC0908-FD7D-4F17-9C43-ABC9F6CFEDA1
P2860
[Practice guidelines for management of hepatocellular carcinoma 2009].
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
[Practice guidelines for management of hepatocellular carcinoma 2009].
@en
[Practice guidelines for management of hepatocellular carcinoma 2009].
@nl
type
label
[Practice guidelines for management of hepatocellular carcinoma 2009].
@en
[Practice guidelines for management of hepatocellular carcinoma 2009].
@nl
prefLabel
[Practice guidelines for management of hepatocellular carcinoma 2009].
@en
[Practice guidelines for management of hepatocellular carcinoma 2009].
@nl
P1476
[Practice guidelines for management of hepatocellular carcinoma 2009].
@en
P2093
Korean Liver Cancer Study Group and National Cancer Center, Korea
P304
P356
10.3350/KJHEP.2009.15.3.391
P577
2009-09-01T00:00:00Z